Positron is committed to expanding the cardiac and oncology PET modality by delivering the best technology and value to imaging specialists and will continue to advance its technology through its ...

The FDA granted fast track designation to 64Cu-SAR-bisPSMA for PET imaging of PSMA-positive prostate cancer lesions in ...

An imaging technique called 18F-FAPI PET may be able to detect early signs of changes in blood vessel tissues in PAH, a new ...

Positron is committed to expanding the cardiac and oncology PET modality by delivering the best technology and value to imaging specialists and will continue to advance its technology through its ...

Clarity Pharmaceuticals (ASX:CU6) has seen the U.S. FDA fast-track its prostate cancer imaging compound for use in PET scans on patients with recurring prostate cancer. The stock jumped 4% in the ...

FAPI PET—can detect the first signs of tissue remodeling in patients with pulmonary arterial hypertension (PAH), providing ...

Christina Henson, MD, discussed some of the current imaging guidelines in head and neck cancer, with a focus on extranodal ...

making them visible on PET scans and providing functional imaging that reveals the biological activity of cancer. This functional imaging can significantly ‘enhance’ the accuracy of disease ...

PSMA-PET imaging uses tiny amounts of radioactive “tracers,” called radiotracers, that binds to prostate cancer cells, making them visible on PET scans. Unlike conventional imaging, which provides ...

PSMA-PET imaging uses tiny amounts of radioactive "tracers," called radiotracers, that binds to prostate cancer cells, making them visible on PET scans. Unlike conventional imaging, which provides ...

PSMA-PET imaging uses tiny amounts of radioactive "tracers," called radiotracers, that binds to prostate cancer cells, making them visible on PET scans. Unlike conventional imaging, which provides ...